» Articles » PMID: 36404257

Agent-based Methods Facilitate Integrative Science in Cancer

Overview
Specialty Cell Biology
Date 2022 Nov 20
PMID 36404257
Authors
Affiliations
Soon will be listed here.
Abstract

In this opinion, we highlight agent-based modeling as a key tool for exploration of cell-cell and cell-environment interactions that drive cancer progression, therapeutic resistance, and metastasis. These biological phenomena are particularly suited to be captured at the cell-scale resolution possible only within agent-based or individual-based mathematical models. These modeling approaches complement experimental work (in vitro and in vivo systems) through parameterization and data extrapolation but also feed forward to drive new experiments that test model-generated predictions.

Citing Articles

Control of medical digital twins with artificial neural networks.

Bottcher L, Fonseca L, Laubenbacher R Philos Trans A Math Phys Eng Sci. 2025; 383(2292):20240228.

PMID: 40078154 PMC: 11904622. DOI: 10.1098/rsta.2024.0228.


Epithelial competition determines gene therapy potential to suppress Fanconi Anemia oral cancer risk.

Colegrove H, Monnat R, Monnat Jr R, Feder A bioRxiv. 2025; .

PMID: 40060430 PMC: 11888451. DOI: 10.1101/2025.02.26.640284.


Emergent Tissue Shapes from the Regulatory Feedback between Morphogens and Cell Growth.

Kaity B, Lobo D bioRxiv. 2025; .

PMID: 40027769 PMC: 11870555. DOI: 10.1101/2025.02.16.638504.


Optimal control of agent-based models via surrogate modeling.

Fonseca L, Bottcher L, Mehrad B, Laubenbacher R PLoS Comput Biol. 2025; 21(1):e1012138.

PMID: 39808665 PMC: 11790234. DOI: 10.1371/journal.pcbi.1012138.


New solutions of time-fractional cancer tumor models using modified He-Laplace algorithm.

Qayyum M, Ahmad E, Ali M Heliyon. 2024; 10(14):e34160.

PMID: 39669766 PMC: 11637049. DOI: 10.1016/j.heliyon.2024.e34160.


References
1.
Edwards J, Marusyk A, Basanta D . Selection-driven tumor evolution with public goods leads to patterns of clonal expansion consistent with neutral growth. iScience. 2020; 24(1):101901. PMC: 7753957. DOI: 10.1016/j.isci.2020.101901. View

2.
El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y . Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer. Br J Cancer. 2019; 121(7):556-566. PMC: 6889319. DOI: 10.1038/s41416-019-0542-2. View

3.
Anderson A, Quaranta V . Integrative mathematical oncology. Nat Rev Cancer. 2008; 8(3):227-34. DOI: 10.1038/nrc2329. View

4.
Lloyd M, Cunningham J, Bui M, Gillies R, Brown J, Gatenby R . Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces. Cancer Res. 2016; 76(11):3136-44. PMC: 5384728. DOI: 10.1158/0008-5472.CAN-15-2962. View

5.
Bailey K, Wojtkowiak J, Hashim A, Gillies R . Targeting the metabolic microenvironment of tumors. Adv Pharmacol. 2012; 65:63-107. PMC: 3796340. DOI: 10.1016/B978-0-12-397927-8.00004-X. View